Please note: In order to keep Hive up to date and provide users with the best features, we are no longer able to fully support Internet Explorer. The site is still available to you, however some sections of the site may appear broken. We would encourage you to move to a more modern browser like Firefox, Edge or Chrome in order to experience the site fully.

Overcoming Cancers Resistant to HER-2 Antibodies : Volume 3, Hardback Book

Overcoming Cancers Resistant to HER-2 Antibodies : Volume 3 Hardback

Edited by Benjamin (Professor, Department of Microbiology, Immunology and Molecular Genetics, David Bonavida

Part of the Breaking Tolerance to Antibody-Mediated Immunotherapy series

Hardback

Description

Overcoming Cancers Resistant to HER-2 Antibodies provides general updated information on the resistance of various human cancers to anti-HER2 therapeutic antibodies.

The book also discusses the description of various sensitizing agents that can reverse resistance when used in combination with anti-HER2 antibodies.

There have been a lot of reports in which the treatment with anti-HER2 antibodies for various cancers has resulted in clinical responses; however, there have been also subsets of cancer patients who did not respond initially, and several responding patients developed resistance following treatments.

Sections cover Lapatinib, Ganetespib, Paclitaxel, Celecoxib, Emantasine, Liposomal Doxorubicin, and Kinase Inhibitors. This book is a valuable source for cancer researchers, oncologists, pharmacologists and different members of the biomedical field interested in fighting cancer resistance to HER-2 antibodies.

Information

£115.00

 
Free Home Delivery

on all orders

 
Pick up orders

from local bookshops

Information

Also in the Breaking Tolerance to Antibody-Mediated Immunotherapy series